My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 496

    1.

    Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study.

    de Pont AC, Hofstra JJ, Pik DR, Meijers JC, Schultz MJ.

    Crit Care. 2007;11(5):R102.PMID: 17854496 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients.

    Lindhoff-Last E, Betz C, Bauersachs R.

    Clin Appl Thromb Hemost. 2001 Oct;7(4):300-4.PMID: 11697713 [PubMed - indexed for MEDLINE]Related articles

    3.

    Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.

    Wilde MI, Markham A.

    Drugs. 1997 Dec;54(6):903-24. Review. Erratum in: Drugs 1998 Apr;55(4):517. PMID: 9421696 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.

    Chong BH, Gallus AS, Cade JF, Magnani H, Manoharan A, Oldmeadow M, Arthur C, Rickard K, Gallo J, Lloyd J, Seshadri P, Chesterman CN; Australian HIT Study Group.

    Thromb Haemost. 2001 Nov;86(5):1170-5.PMID: 11816702 [PubMed - indexed for MEDLINE]Related articles

    5.

    A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia.

    Farner B, Eichler P, Kroll H, Greinacher A.

    Thromb Haemost. 2001 Jun;85(6):950-7.PMID: 11434701 [PubMed - indexed for MEDLINE]Related articles

    6.

    Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.

    Westphal K, Martens S, Strouhal U, Matheis G, Lindhoff-Last E, Wimmer-Greinecker G, Lischke V.

    Thorac Cardiovasc Surg. 1997 Dec;45(6):318-20.PMID: 9477469 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.

    Polkinghorne KR, McMahon LP, Becker GJ.

    Am J Kidney Dis. 2002 Nov;40(5):990-5.PMID: 12407644 [PubMed - indexed for MEDLINE]Related articles

    8.

    Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study.

    de Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF.

    Crit Care Med. 2000 Feb;28(2):421-5.PMID: 10708177 [PubMed - indexed for MEDLINE]Related articles

    9.

    Treatment of 51 pregnancies with danaparoid because of heparin intolerance.

    Lindhoff-Last E, Kreutzenbeck HJ, Magnani HN.

    Thromb Haemost. 2005 Jan;93(1):63-9.PMID: 15630492 [PubMed - indexed for MEDLINE]Related articles

    10.

    On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.

    Schenk JF, Pindur G, Stephan B, Mörsdorf S, Mertzlufft F, Kroll H, Wenzel E, Seyfert UT.

    Clin Appl Thromb Hemost. 2003 Jan;9(1):25-32.PMID: 12643320 [PubMed - indexed for MEDLINE]Related articles

    11.

    Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.

    Kodityal S, Manhas AH, Udden M, Rice L.

    Eur J Haematol. 2003 Aug;71(2):109-13.PMID: 12890149 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial.

    de Valk HW, Banga JD, Wester JW, Brouwer CB, van Hessen MW, Meuwissen OJ, Hart HC, Sixma JJ, Nieuwenhuis HK.

    Ann Intern Med. 1995 Jul 1;123(1):1-9.PMID: 7539233 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Heparin versus danaparoid in off-pump coronary bypass grafting: results of a prospective randomized clinical trial.

    Carrier M, Robitaille D, Perrault LP, Pellerin M, Pagé P, Cartier R, Bouchard D.

    J Thorac Cardiovasc Surg. 2003 Feb;125(2):325-9.PMID: 12579101 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations.

    Gitlin SD, Deeb GM, Yann C, Schmaier AH.

    J Vasc Surg. 1998 Mar;27(3):568-75.PMID: 9546248 [PubMed - indexed for MEDLINE]Related articles

    15.

    Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.

    Dworschak M, Hiesmayr JM, Lassnigg A.

    Ann Thorac Surg. 2002 May;73(5):1626-7. Erratum in: Ann Thorac Surg 2002 Aug;74(2):635. PMID: 12022563 [PubMed - indexed for MEDLINE]Related articles

    16.

    Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism.

    Bauer C, Vichova Z, Ffrench P, Hercule C, Jegaden O, Bastien O, Lehot JJ.

    Anesth Analg. 2008 Apr;106(4):1101-3, table of contents.PMID: 18349178 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hirudin in heparin-induced thrombocytopenia.

    Lubenow N, Greinacher A.

    Semin Thromb Hemost. 2002 Oct;28(5):431-8. Review.PMID: 12420238 [PubMed - indexed for MEDLINE]Related articles

    18.

    Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004.

    Magnani HN, Gallus A.

    Thromb Haemost. 2006 Jun;95(6):967-81. Review.PMID: 16732376 [PubMed - indexed for MEDLINE]Related articles

    19.

    Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.

    Lubenow N, Greinacher A.

    Am J Cardiovasc Drugs. 2001;1(6):429-43. Review.PMID: 14728002 [PubMed - indexed for MEDLINE]Related articles

    20.

    Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.

    Severin T, Zieger B, Sutor AH.

    Semin Thromb Hemost. 2002 Oct;28(5):447-54. Review.PMID: 12420240 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity